期刊文献+

下呼吸道感染铜绿假单胞菌耐药性分析 被引量:6

Drug resistance analysis of Pseudomonas aeruginosa causing lower respiratory infection
下载PDF
导出
摘要 目的了解该地区下呼吸道感染铜绿假单胞菌(PAE)对抗菌药物的耐药性,为临床预防医院内感染及合理使用抗菌药物提供科学依据。方法采集2010年10月1日至2011年10月1日下呼吸道感染标本,应用常规方法进行细菌培养、鉴定,并对分离的PAE采用K-B法进行12种临床常用抗菌药物体外药敏试验。结果 PAE对抗感染药物敏感率以头孢他啶(70.75%)、哌拉西林/他唑巴坦(60.85%)最高,其余依次为美罗培南(59.43%)、阿米卡星(58.96%)和哌拉西林(55.66%)等;而耐药率较高者为头孢噻肟、庆大霉素等;总体来看,PAE耐药情况比较严重。结论下呼吸道感染PAE存在单一及多重耐药性,需引起高度重视,医院须加强预防措施,切实降低PAE医院内感染率。 Objective To explore the drug resistance of Pseudomonas aeruginosa(PAE) causing lower respiratory infection, so as to provide scientific basis for controlling nosocomial infection and rational usage of antibiotics. Methods Samples of lower respiratory tract were collected during October 1,20.10 to October 1,2011 and detected for pathogenic bacteria by using routine methods. K-B method was performed for the detection of drug resistance of isolated PAE strains to 12 kinds of commonly used antibiotics. Results The drug resistance rates of PAE stains to Ceftazidime, Piperacillin/Tazobactam, Meropenem, Amikacin, Piperacillin were 70.75%, 60.85%, 59.43%, 58.96% and 55.66%, and to Cefotaxime and Cefotaxime were relatively high. Overall, the drug resistance of PAE might be serious. Conclusion PAE, causing lower respiratory infection, might be with single or multi-- drug resistance, which should be paid for more attention. Preventive measures should be strengthened to reduce nosocomial infection of PAE.
作者 邱燕 吴蓉
出处 《国际检验医学杂志》 CAS 2012年第10期1219-1220,共2页 International Journal of Laboratory Medicine
关键词 假单胞菌 铜绿 呼吸道感染 交叉感染 抗菌药 抗药性 pseudomonas aeruginosa respiratory tract infections cross infection anti-bacterial agents drug resistance
  • 相关文献

参考文献10

二级参考文献83

共引文献301

同被引文献56

  • 1陈文昭,吴爱华,谢轶.2006年四川大学华西医院呼吸科常见病原菌耐药分析[J].华西医学,2007,22(4):783-784. 被引量:3
  • 2吴礼襄,萧正伦,黎毅敏.MRSA呼吸系统医院感染的分子流行病学调查[J].中华医院感染学杂志,2004,14(4):453-457. 被引量:76
  • 3朱以军,徐瑞龙,单小云,卜黎红,赵硕.医院感染葡萄球菌属的分布特点与耐药性[J].中华医院感染学杂志,2007,17(5):599-601. 被引量:27
  • 4刘恒玮,王霄.呼吸内科下呼吸道感染的病原菌分布及耐药性分析[J].临床医学,2010,23(6):52-53.
  • 5Clinical and laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing [ S ]. MIO0-S18. CLSI, 2008:116-118.
  • 6中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病的诊疗指南(2007修订版)[J].中华结核和呼吸杂志,2007,30(1):8217.
  • 7Faleone M,Venditti M,Corrao S,et al. Role of multidrug-re- sistant pathogens in health-care-associated pneumonia [J]. Lancet Infect Dis,2011,11(1)tll-12.
  • 8M:01hak K. The past decade's infectious diseases[J]. Ugeskr Laeger, 2011,173(6) :414-416.
  • 9Miravitlles M,Sotgiu G,Dimopoulos G,et al. The best on in- fections:update from the 2010 ERS congressEJ]. Eur Respir J,2011,38(2) :450-455.
  • 10Yang X,Strobel M,Tian L,etal. Bacterial flora in acute exac- erbations of chronic obstructive pulmonary disease(COPD)in Kunming,China[J]. Med Mal Infect,2011,41(4) : 186-191.

引证文献6

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部